These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 16771951

  • 1. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

  • 2. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L, Bueno L, Wittmann T.
    Digestion; 2012 Jun; 85(1):40-6. PubMed ID: 22179430
    [Abstract] [Full Text] [Related]

  • 3. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [Abstract] [Full Text] [Related]

  • 4. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 6. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 7. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
    van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA.
    Am J Gastroenterol; 2005 Nov; 100(11):2510-6. PubMed ID: 16279907
    [Abstract] [Full Text] [Related]

  • 8. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):994-1002. PubMed ID: 18671775
    [Abstract] [Full Text] [Related]

  • 9. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb 15; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

  • 10. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, Coëffier M.
    Am J Gastroenterol; 2011 Dec 15; 106(12):2165-73. PubMed ID: 22008894
    [Abstract] [Full Text] [Related]

  • 11. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.
    J Gastroenterol Hepatol; 2006 Jan 15; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM, Gong J, Dong L, Xu JR.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep 15; 27(9):1345-7. PubMed ID: 17884774
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
    Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A.
    Am J Gastroenterol; 2005 Feb 15; 100(2):373-82. PubMed ID: 15667495
    [Abstract] [Full Text] [Related]

  • 15. Lactose intolerance in patients with irritable bowel syndrome from northern India: a case-control study.
    Gupta D, Ghoshal UC, Misra A, Misra A, Choudhuri G, Singh K.
    J Gastroenterol Hepatol; 2007 Dec 15; 22(12):2261-5. PubMed ID: 17559357
    [Abstract] [Full Text] [Related]

  • 16. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bôle-Feysot C, Déchelotte P, Reimund JM, Ducrotté P.
    Am J Gastroenterol; 2010 May 15; 105(5):1181-8. PubMed ID: 19997094
    [Abstract] [Full Text] [Related]

  • 17. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP, Nandasiri SD, Hewavisenthi J, Manamperi A, Ariyasinghe MP, Dassanayake AS, Jewell DP, de Silva HJ.
    Scand J Gastroenterol; 2012 Jun 15; 47(6):619-24. PubMed ID: 22486731
    [Abstract] [Full Text] [Related]

  • 18. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW.
    J Gastroenterol Hepatol; 2008 Nov 15; 23(11):1689-94. PubMed ID: 19120860
    [Abstract] [Full Text] [Related]

  • 19. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.
    Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D, Pierdomenico SD, Cuccurullo F, Neri M.
    Am J Gastroenterol; 2005 Feb 15; 100(2):383-9. PubMed ID: 15667496
    [Abstract] [Full Text] [Related]

  • 20. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope].
    Kong WM, Gong J, Dong L, Chen MX.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug 15; 27(8):1167-70, 1172. PubMed ID: 17715017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.